BioLineRx Ltd Working Capital to Net Assets Ratio
BioLineRx Ltd working capital to net assets ratio. BioLineRx Ltd (BLRX) has a Working Capital to Net Assets ratio of 16.1% as of June 2026. Working capital of $2.67 Million (current assets of $16.35 Million minus current liabilities of $13.68 Million) is measured against net assets of $16.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check BioLineRx Ltd (BLRX) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BioLineRx Ltd (2008–2025)
Working capital to net assets ratio of BioLineRx Ltd from 2008 to 2025. This chart shows how BioLineRx Ltd's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the ratio stands at 16.1%, reflecting working capital of $2.67 Million against net assets of $16.62 Million USD. See BioLineRx Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
BioLineRx Ltd Working Capital to Net Assets Ratio by Year (2008–2025)
BioLineRx Ltd working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BioLineRx Ltd (BLRX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 49.5% | $11.56 Million | $23.34 Million | $23.68 Million | $12.12 Million | ▼ -37.4 pp |
| 2024 | 86.9% | $11.70 Million | $13.46 Million | $27.10 Million | $15.41 Million | ▲ +53.6 pp |
| 2023 | 33.3% | $4.40 Million | $13.22 Million | $47.18 Million | $42.78 Million | ▼ -48.0 pp |
| 2022 | 81.3% | $41.32 Million | $50.84 Million | $52.00 Million | $10.68 Million | ▲ +11.2 pp |
| 2021 | 70.0% | $47.69 Million | $68.09 Million | $57.40 Million | $9.72 Million | ▲ +14.5 pp |
| 2020 | 55.6% | $12.24 Million | $22.03 Million | $22.88 Million | $10.64 Million | ▲ +6.9 pp |
| 2019 | 48.7% | $16.24 Million | $33.38 Million | $28.21 Million | $11.97 Million | ▼ -12.4 pp |
| 2018 | 61.1% | $25.23 Million | $41.32 Million | $31.98 Million | $6.75 Million | ▼ -21.5 pp |
| 2017 | 82.6% | $43.65 Million | $52.88 Million | $50.38 Million | $6.72 Million | ▼ -10.1 pp |
| 2016 | 92.6% | $32.44 Million | $35.03 Million | $36.10 Million | $3.66 Million | ▼ -2.0 pp |
| 2015 | 94.6% | $45.04 Million | $47.61 Million | $48.18 Million | $3.14 Million | ▼ -6.8 pp |
| 2014 | 101.4% | $32.21 Million | $31.77 Million | $35.11 Million | $2.90 Million | ▼ -33.2 pp |
| 2013 | 134.6% | $15.72 Million | $11.68 Million | $18.77 Million | $3.05 Million | ▲ +29.3 pp |
| 2012 | 105.2% | $15.75 Million | $14.97 Million | $22.18 Million | $6.43 Million | ▲ +14.7 pp |
| 2011 | 90.5% | $20.40 Million | $22.53 Million | $27.16 Million | $6.75 Million | ▼ -3.4 pp |
| 2010 | 93.9% | $35.00 Million | $37.26 Million | $41.27 Million | $6.27 Million | ▲ +4.2 pp |
| 2009 | 89.7% | $27.93 Million | $31.13 Million | $38.82 Million | $10.88 Million | ▲ +6.5 pp |
| 2008 | 83.2% | $17.27 Million | $20.75 Million | $27.15 Million | $9.88 Million | — |